Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aeglea Biothera (NQ: AGLE )

0.5821 -0.0679 (-10.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,694,189
Open 0.6500
Bid (Size) 0.5821 (11)
Ask (Size) 0.6100 (23)
Prev. Close 0.6500
Today's Range 0.5821 - 0.6510
52wk Range 0.5850 - 8.500
Shares Outstanding 50,419,822
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
79 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it... 
Via Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. 
Via Benzinga

Performance

YTD
-87.80%
-87.80%
1 Month
-57.51%
-57.51%
3 Month
-76.81%
-76.81%
6 Month
-86.17%
-86.17%
1 Year
-91.09%
-91.09%

More News

Read More
Aeglea Bio Stock Gains On Additional Pegzilarginase Data For Rare Metabolic Disease
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022
Via Benzinga
74 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Surges Over 200 Points; Immunic Shares Slide
Via Benzinga
Mid-Day Market Update: U.S. Stocks Turn Positive; Nasdaq Jumps 150 Points
Via Benzinga
53 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Aeglea BioTherapeutics Shares Plummet Following Refusal To File Letter From FDA
Via Benzinga
Aeglea BioTherapeutics Earnings Perspective: Return On Capital Employed
Via Benzinga
Aeglea BioTherapeutics: Q1 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More
Via Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Aeglea BioTherapeutics's Return On Capital Employed Overview
Via Benzinga
Aeglea BioTherapeutics: Q4 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.